Background-Whereas in the past, androgens were mainly believed to exert adverse effects on the cardiovascular system, recent experimental data postulate a benefit of testosterone for recovery of myocardial function after ischemia/ reperfusion injury. Thus, we examined whether testosterone might improve myocardial tolerance to ischemia due to activation of mitochondrial (mitoK ATP ) and/or sarcoplasmatic (sarcK ATP ) K ATP channels. Methods and Results-In a cellular model of ischemia, testosterone significantly decreased the rate of ischemia-induced death of cardiomyocytes that could be prevented by 5-hydroxydecainoic acid but was unaffected by the sarcK ATP blocker HMR1098 and the testosterone receptor antagonist flutamide. To index mitoK ATP , mitochondrial flavoprotein fluorescence was measured. Testosterone induced a highly significant increase in mitochondrial flavoprotein fluorescence in intact myocytes and isolated mitoplasts that could be abolished by 5-hydroxydecainoic acid. Testosteronemediated flavoprotein oxidation of mitoplasts was K ϩ dependent and ATP sensitive. In mitoplast-attached singlechannel recordings, testosterone directly activated an ATP-sensitive K ϩ channel of the inner mitochondrial membrane. Addition of the K ATP channel opener diazoxide and pinacidil to the cytosolic solution activated the ATP-sensitive K ϩ current comparable to testosterone, whereas 5-hydroxydecainoic acid and glibenclamide inhibited the testosteroneinduced current. Patch-clamp experiments of intact myocytes in whole-cell configuration did not demonstrate any effect of testosterone on sarcK ATP channels. Conclusions-Our results provide direct evidence for the existence of cardiac mitoK ATP and a link between testosteroneinduced cytoprotection and activation of mitoK ATP . Endogenous testosterone might play a more important role in recovery after myocardial infarction than is currently assumed. (Circulation. 2004;110:3100-3107.) 
M ale gender is a classic risk factor for cardiovascular disease. The mortality and incidence of coronary heart disease in middle-aged men is much higher than in premenopausal women of similar age. 1 This significant gender difference has been attributed at least in part to negative effects of testosterone on the cardiovascular system. 1, 2 Androgens have been associated with an increased cardiovascular risk by adversely affecting the plasma lipid and lipoprotein profile, thrombosis, cardiac hypertrophy, and suspected proatherogenic effects. 3, 4 However, beside these genetic, mainly testosterone receptor-mediated pathways, recent studies demonstrate another, genomic-independent way of testosterone action. Short-term administration of testosterone acutely induces vasodilation in the systemic, coronary, and pulmonary vascular beds. 5 Thus, testosterone might actually increase myocardial tolerance to ischemia. Indeed, testosterone substitution in orchiectomized rats improved recovery of myocardial function after ischemia/reperfusion injury. 6 Although this beneficial effect might have been related in part to acute coronary vasodilation by testosterone, 5 we hypothesized that in addition testosterone might exhibit direct cytoprotective actions on the myocardium. Mitochondria are increasingly recognized as key players in cell survival. 7 Indirect evidence suggests that multiple diverse signaling pathways converge on ATP-sensitive potassium channels of the inner mitochondrial membrane (mitoK ATP ) as the final effectors of cytoprotection against necrotic and apoptotic cardiac or neural ischemic injury. 8 -11 First published data that provided evidence for the existence of mitoK ATP came from patch-clamping liver fused giant mitoplasts. 12 Subsequently, characterization of putative mitoK ATP channels has utilized reconstitution of detergent-solubilized mitochondrial membranes into proteoliposomes. [13] [14] [15] However, both preparations bear the risk of contamination by membrane fragments of other organelles and the sarcolemma. 16 Indeed, recently the involvement and even the existence of mitoK ATP have been questioned by several investigators since K ATP channelindependent effects of pharmacological K ATP channel openers and inhibitors on mitochondrial metabolism and membrane potential have been identified. 16 -19 The patch-clamp technique of freshly isolated, single mitochondria solves this problem, but its implementation is a severe technical challenge. Here we patch-clamp single mitoplasts (2-to 5-m vesicles of inner mitochondrial membrane) isolated from rat cardiocytes to measure single-channel K ATP currents directly. Our results provide direct evidence for the existence of cardiac mitoK ATP and a link between testosterone-induced cytoprotection and activation of mitoK ATP .
Methods

Preparation of Myocytes and Mitoplasts
Single ventricular cells were isolated from Sprague-Dawley rats (weight, 200 to 250 g) by enzymatic digestion, as previously described. 20 Freshly isolated myocytes were used within 12 hours. For mitoplast imaging and patch-clamp studies, myocytes were labeled with tetramethylrhodamine ethyl ester 6 mol/L (TMRE) (Sigma) and Mitotracker Green 1 mol/L (Molecular Probes, Inc), respectively, to facilitate identification of intact mitoplasts after further subcellular purification. Isolated intact mitochondria and mitoplasts were prepared as previously described. 21, 22 Mitoplasts appeared as transparent 2-to 5-m vesicles with bright red and green fluorescence, indicating retention of TMRE and Mitotracker Green, respectively.
Flavoprotein Fluorescence and Mitochondrial Imaging
Images were obtained as previously described with a Leica TCS SP2 confocal laser-scanning microscope equipped with a DM IRE2 inverted fluorescence microscope and argon/helium-neon lasers at room temperature 21°C to 22°C. 8 To localize mitochondria in isolated myocytes and intact mitoplasts, TMRE fluorescence was excited with the 543-nm line of a helium-neon laser, and emission was recorded at Ͼ600 nm. For flavoprotein fluorescence, measurement fluorescence was excited at 488 nm with an argon laser, and the emission was recorded at 505 to 535 nm. In each experiment the endogenous flavoprotein fluorescence of the myocytes or mitoplasts was recorded. To determine the redox potential, the maximum fluorescence was determined with dinitrophenol (DNP) (Sigma), and minimum fluorescence was determined with sodium cyanide (CN) (Sigma), respectively. The difference between DNP and CN fluorescence intensity was assumed as 100% fluorescence. The fluorescence intensity with the test substances was calculated accordingly. Images were analyzed simultaneously during acquisition on a personal computer with the software program Leica TCS SL. For mitoplast imaging, the bath solution contained the following (in mmol/L): KCl 140, glucose 10, MgCl 2 1, HEPES 10; pH was 
Electrophysiology
Mitoplasts were approached with glass pipettes having tip resistance values of Ϸ30 to 50 M⍀ and drawn toward the tip by applying gentle suction. Seal resistance values of 10 to 15 G⍀ were obtained, and experiments were performed in mitoplast-attached mode with symmetrical bath and pipette solution composed of KCl 150 mmol/L and HEPES 10 mmol/L; pH was adjusted to 7.2 with KOH. The sarcolemmal I KATP of isolated myocytes was recorded with the use of standard microelectrode whole-cell patch-clamp technique. The bath solution contained the following (in mmol/L): NaCl 135, KCl 5, glucose 10, MgCl 2 1, HEPES 10; pH was adjusted to 7.4 with NaOH. The pipette solution was composed of the following (in mmol/L): KCl 120, NaCl 15, EGTA 10, MgCl 2 1, HEPES 10, and Mg-ATP 1; pH was adjusted to 7.2 with KOH. Experiments were performed at room temperature (21°C to 22°C). Currents were recorded and digitized with an Axopatch 200B amplifier and Digidata 1200 interface (Axon Instruments) with the use of custom software.
Single-Channel Analysis
Open probability (defined as the relative occupancy of the open state during active sweeps), availability (fraction of sweeps containing at least 1 channel opening), and I peak (the peak ensemble average current, obtained visually) were analyzed from single-channel and multichannel patches at Ϫ70 mV (if not otherwise indicated). In the latter case, they were corrected for the number of the channels in the patch (n). n was defined as the maximum current amplitude observed, divided by the unitary current. Peak current was corrected by division through n. The availability was corrected by the square root method: (1Ϫavailability corrected ) is the n th root of (1Ϫavailability uncor - determined by direct measurements for conductance calculation or as the maximum of gaussian fits to all-point amplitude histograms. Time-dependent inactivation was determined after 150 ms as percentage of the respective I peak . The voltage dependence of activation was analyzed with the use of the Boltzmann function.
Simulated Ischemia and Cell Injury
The cell injury model has been described previously. 8, 23 Briefly, cardiomyocytes were incubated in a 1.5-mL tube in buffer containing the following (in mmol/L): NaCl 119, NaHCO 3 25, KH 2 PO 4 1.2, KCl 4.8, MgSO 4 1.2, HEPES 10, CaCl 2 1, glucose 11. In some experiments test substances were added to the buffer, as indicated. After 20 minutes of incubation, cells were centrifuged to a pellet, and gaseous diffusion was prevented with a layer of mineral oil. After 60 minutes of pelleting, probes of each sample were mixed with hypotonic trypan blue solution, as previously described. 8 Cells permeable to trypan blue were counted as dead by 2 blinded investigators (G.M., N.G.) and expressed as a percentage of total cells counted (Ͼ200 for each sample).
Materials and Statistical Analysis
In some experiments, ATP, androstenedione, diazoxide, dihydrotestosterone (testosterone), flutamide, glibenclamide, 5-hydroxydecainoic acid (5-HD), pinacidil, paxilline, the adenine nucleotide translocator (ANT) blocker carboxyatractyloside 24 (Sigma), or HMR1098 (Aventis Pharm) was added to the bath solutions, as indicated. Pooled data are presented as meanϮSEM. Comparisons between groups were performed with 1-way ANOVA. Probability values of PϽ0.05 were deemed significant.
Results
Testosterone Induces Mitochondrial Flavoprotein Oxidation in Intact Myocytes
To obtain initial evidence regarding whether testosterone exhibited effects on myocardial mitochondria, mitochondrial flavoprotein fluorescence was measured in isolated rat ventricular myocytes. Confocal images of single cardiomyocytes were obtained at baseline, testosterone loaded, fully oxidized with 100 mol/L DNP, and fully reduced with 5 mmol/L CN ( Figure 1A to 1E ). There were virtually no differences in fluorescence intensity between baseline and CN. Testosterone (10 mol/L) significantly increased the mitochondrial flavoprotein fluorescence relative to DNP oxidation to 48.8Ϯ2.6% (nϭ6; PϽ0.001 versus baseline; Figure 1B to 1D, 1F), whereas androstenedione (100 mol/L), a precursor of testosterone, did not induce flavoprotein oxidation (nϭ5). The testosterone-induced flavoprotein oxidation was dose dependent (10 Ϫ9 mol/L: 4.7Ϯ0.5%, nϭ3; 10 Ϫ8 mol/L: 9.7Ϯ1.2%, nϭ3; 10 Ϫ7 mol/L: 10.1Ϯ1.6%, nϭ5; 10 Ϫ6 mol/L: 37.8Ϯ3.1%, nϭ4; 10 Ϫ5 mol/L: 87.0Ϯ3.1%, nϭ6; 10 Ϫ4 mol/L: 95.2Ϯ2.9%, nϭ5) ( Figure 1H ). Thus, the first increase of flavoprotein oxidation could be observed at physiological testosterone concentrations in men. 25 The K ATP channel blocker 5-HD virtually abolished the testosterone-induced mitochondrial oxidation ( Figure 1G ). 5-HD (100 mol/L) blocked 79% to 90% of the testosterone-induced flavoprotein oxidation at testosterone concentrations of 10 Ϫ9 to 10 Ϫ4 mol/L (PϽ0.001). Addition of the testosterone receptor antagonist flutamide (10 mol/L) did not prevent the testosterone (10 mol/L)-induced flavoprotein oxidation (46.8Ϯ5.9%; nϭ4), indicating that the effect was not mediated by the testosterone receptor. Recently, mitochondrial Ca 2ϩ -activated K ϩ channels (mitoK Ca ) have been implicated to play a role in cytoprotection. 21 However, the mitoK Ca antagonist paxilline (10 mol/L) exhibited no effect on testosteroneinduced flavoprotein oxidation (nϭ4), excluding a contribution of mitoK Ca . These results suggested that testosterone oxidized cardiac mitochondria in a testosterone receptor-independent way, possibly by activating mitoK ATP .
Testosterone Directly Oxidizes Mitoplasts in a K ؉ -Dependent and ATP-Sensitive Manner
To examine whether testosterone exerted a direct effect on mitochondria, measurements of mitochondrial flavoprotein fluorescence were repeated with the use of isolated mitoplasts (Figure 2A to 2E ). Confocal images of cardiac mitoplasts revealed that testosterone (10 mol/L) directly and significantly increased mitoplast flavoprotein fluorescence to 60.3Ϯ1.9% relative to the fully oxidized state with 100 mol/L DNP (nϭ5; PϽ0.001 versus baseline; Figure 2B to 2D, 2F). Elimination of K ϩ in the bath entirely abolished the testosterone-induced oxidation of mitoplasts (nϭ4), indicating that the testosterone effect was mediated via mitochondrial K ϩ influx ( Figure 2G ). Similar to intact myocytes, 5-HD (100 mol/L) suppressed the testosterone-induced mitoplast oxidation ( Figure 2F ), whereas flutamide (10 mol/L) did not affect the testosterone-induced mitoplast oxidation (nϭ3). 
Effects of Testosterone, Diazoxide, 5-HD, and ATP on Single-Channel Behavior of MitoK ATP
Er et al Testosterone Activates Mitochondrial K ؉ Channel
Notably, ATP (5 mmol/L) also abolished the increase of mitoplast flavoprotein fluorescence on exposure to testosterone (nϭ4) ( Figure 2H ), providing further evidence for the contribution of a putative ATP-sensitive K ϩ channel.
Testosterone Activates K ATP Channels of the Inner Mitochondrial Membrane
To directly characterize the effect of testosterone on mitochondrial K ϩ flux, single-channel patch-clamp recordings of mitoplasts were performed. Testosterone (10 mol/L) activated single-channel currents with a unitary conductance of 13.0Ϯ1.3 pS ( Figure 3C; nϭ10) when the pipette solution contained 150 mmol/L K ϩ ( Figure 3A ; Table) . The channel activity increased with more negative test potentials ( Figure  3B, 3D, 3E) . These K ϩ currents were blocked on application of ATP (5 mmol/L) to the cytosolic solution ( Figure 3A) . ATP block was prevented by the addition of the ANT blocker carboxyatractyloside (10 mol/L) to the bath solution. This suggests that ATP was transported via the ANT into the mitoplasts and that the regulatory channel site for ATP faces the mitochondrial matrix. The I-V relation for the testosterone-activated current showed that the reversal potential estimated by linear regression was 0 mV, which is nearly equal to the equilibrium potential for K ϩ (E K ) when an intramitochondrial K ϩ concentration of 180 mmol/L is assumed 14 (Figure 3B, 3C ). Flutamide (10 mol/L) did not inhibit testosterone-induced K ϩ channel activation (nϭ4). Androstenedione (100 mol/L) had no effect on mitoplastattached single K ϩ channel activity compared with control (nϭ3) ( Figure 4C ). Addition of the K ATP channel openers diazoxide (100 mol/L) or pinacidil (100 mol/L) to the cytosolic solution activated the ATP-sensitive K ϩ current comparable to testosterone, whereas 5-HD (100 mol/L) and Table) . These results indicate that the testosterone-, diazoxide-, and pinacidil-activated current was mitoK ATP .
Testosterone Does Not Affect Sarcoplasmatic K ATP Channels
To test whether testosterone exhibits any effect on sarcoplasmatic K ATP (sarcK ATP ) channels, which also have been proposed to play a potential role in cytoprotection, 26 patch-clamp current recordings in the whole-cell configuration of isolated cardiomyocytes were performed. Currents of freshly isolated myocytes were consecutively recorded in bath solution (control) and bath solution supplemented with testosterone and pinacidil, respectively. As expected, 100 mol/L pinacidil significantly increased sarcK ATP current density measured at 100 mV from 2.23Ϯ0.13 pA/pF (control) to 10.85Ϯ0.49 pA/pF (nϭ11; PϽ0.001) (Figure 6A, 6B) . Conversely, testosterone at concentrations of 1 mol/L (2.24Ϯ0.21 pA/pF; nϭ7), 10 mol/L (2.26Ϯ0.30 pA/pF; nϭ9), and 100 mol/L (2.21Ϯ0.14 pA/pF; nϭ11) did not increase sarcK ATP current size compared with control cells (PϭNS versus control for all concentrations). To probe any blocking effect of testosterone on sarcK ATP , myocytes were simultaneously perfused with 100 mol/L pinacidil and 100 mol/L testosterone (nϭ9). The recorded currents were not different compared with pure pinacidil-induced currents (10.98Ϯ0.71 versus 10.85Ϯ0.49 pA/pF at 100 mV; PϭNS), indicating that testosterone does not block sarcK ATP .
Testosterone Prevents Ischemia-Induced Cell Death
To examine whether testosterone-induced mitoK ATP channel opening can protect cardiomyocytes from ischemic cell death, we used an established cell injury model. 8, 23 After 60 minutes of ischemia, the rate of killed cardiomyocytes in the control group was 47.1Ϯ1.8% (nϭ11). Testosterone (10 mol/L) significantly protected the cardiomyocytes and decreased the rate of cell deaths to 24.0Ϯ1.6% (nϭ14; PϽ0.001; Figure  6C ), whereas androstenedione (100 mol/L) did not exhibit cytoprotection (44.0Ϯ3.1%; nϭ8, PϭNS versus control). 5-HD abolished the cardioprotective effect of testosterone (testosterone 10 mol/L plus 5-HD 100 mol/L: 42.5Ϯ1.3%; nϭ12; PϭNS versus control), whereas 5-HD alone had no effect on death rate compared with control (45.8Ϯ2.5%; nϭ6; PϭNS). The sarcolemmal K ATP channel blocker HMR1098 (100 mol/L) and the testosterone receptor blocker flutamide (10 mol/L) did not prevent the testosterone-induced protection of cardiomyocytes (rate of cell death, 23.3Ϯ2.6% [nϭ6] and 25.2Ϯ3.2% [nϭ6], respectively; PϭNS versus testosterone, PϽ0.001 versus control). These results substantiated that the acute protective effect of testosterone is mediated by mitoK ATP channel opening in a testosterone receptor-independent manner.
Discussion
Our results show that testosterone acutely and directly depolarizes and oxidizes cardiac mitochondria in a K ϩ -dependent, ATP-sensitive, and testosterone receptor-independent manner. By patch clamping the cardiac inner mitochondrial membrane, we demonstrate testosterone-induced activation of mitochondrial K ϩ channels, which were inhibited by ATP, 5-HD, and glibenclamide, whereas testosterone exhibited no effect on sarcK ATP channels. Testosterone protected cardiomyocytes from ischemic cell death. When activated, the unitary conductance of rat ventricular mitoK ATP was in the same range as previously estimated. 12, 27 Table. For pinacidil, open ϭ1.91Ϯ0.25 ms, closed,fast ϭ0.42Ϯ0.04 ms, and closed,slow ϭ7.21Ϯ2.16 ms (nϭ3).
In contrast to K ϩ flux measurements of reconstituted channels and inside-out recordings of fused giant mitoplasts, 12, 15, 27 mitoK ATP in intact mitoplasts was virtually inactive in the absence of any K ATP channel openers, which is consistent with the assumption that the mitochondrial inner membrane has a low resting permeability to cations to maintain the mitochondrial transmembrane potential. Because mitoK ATP current in mitoplast-attached patches was activated and blocked when testosterone, diazoxide, or pinacidil and ATP, 5-HD, or glibenclamide, respectively, were added outside the pipette, the relevant regulatory sites for these substances on the channel are likely to face the mitochondrial matrix. MitoK ATP would then be modulated as matrix concentrations of these substances rise in response to transmembrane diffusion or transport. Because mitoK ATP block by ATP was inhibited by the ANT blocker carboxyatractyloside, we hypothesize that ATP enters the mitochondrial matrix via the ANT. Our results now provide a direct link between cytoprotection, mitochondrial oxidation, which was K ϩ -dependent and ATP-sensitive, and activation of mitoK ATP channels. On the basis of our experiments, we conclude that mitoK ATP is recruitable to prevent or mitigate ischemic cardiac and possibly neural injury.
Androgens are known as anabolic sex hormones that act via binding to their nuclear receptor and regulate protein synthesis. 28 In addition, recent experimental data indicated a nongenomic pathway of testosterone action on the cardiovascular system, ie, acute testosterone-mediated vasodilation. 5 Our results now demonstrate, for the first time, an acute direct effect of testosterone on cardiac myocytes as well. Anabolic androgenic steroids have been associated with myocardial ischemia, sudden cardiac death, and hypertension in athletes, leading to the view that androgens are detrimental to the cardiovascular system. 4 However, anabolic androgenic steroids consist of a variety of different steroids with differing pharmacological properties. No clinical study has yet dem-onstrated a conclusive link between physiological testosterone and fatal cardiovascular events. Epidemiological data and an intervention study rather suggest either a neutral or a beneficial effect of natural circulating androgens on coronary heart disease in men. 29 However, detailed experimental and clinical evaluations of chronic testosterone receptor-mediated actions, which might be different from acute effects, are still lacking. Thus, before we draw any clinical conclusions from our findings that testosterone can directly and acutely protect cardiocytes against ischemic injury by opening mitoK ATP channels in isolated cells and mitoplasts, extensive studies of the chronic effects of testosterone in vitro and in vivo are definitely warranted. Figure 6 . Effect of testosterone on sarcK ATP channels and cell death. A and B, I SarcKATP of a single ventricular myocyte and pooled current densities at 100 mV (nϭ11) indicate that 100 mol/L pinacidil significantly increased I SarcKATP compared with control, whereas 100 mol/L testosterone (Testo) had no effect. *PϽ0.001 compared with control and Testo. C, Cellpelleting model of ischemic injury in rat heart. Pooled data showing percent cell death induced by 60 minutes of ischemia demonstrate cytoprotection of testosterone (10 mol/L; nϭ14) compared with control (nϭ11), which was abolished by 100 mol/L 5-HD (Testoϩ5-HD) (nϭ12), whereas 5-HD alone (nϭ6) and 100 mol/L androstenedione (Andro) (nϭ8) had no effect. HMR1098 100 mol/L (nϭ6) and flutamide 10 mol/L (Flut) (nϭ6) did not prevent testosterone-mediated cytoprotection. *PϽ0.001 compared with control, Andro, 5-HD, and Testoϩ5-HD.
